Related Experiment Video
Updated: Mar 15, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Effectiveness of Prenatal Tetanus, Diphtheria, and Acellular Pertussis Vaccination on Pertussis Severity in Infants
Kathleen Winter1,2, James D Cherry3, Kathleen Harriman1
1California Department of Public Health, Immunization Branch, Richmond.
Insights
Maternal tetanus, diphtheria, and acellular pertussis (Tdap) vaccination during pregnancy significantly reduces pertussis severity in infants, lowering hospitalization and intensive care unit admission risks.
Area of Science:
- Immunology
- Pediatrics
- Public Health
Background:
- US guidelines recommend maternal tetanus, diphtheria, and acellular pertussis (Tdap) vaccination during pregnancy.
- The impact of prenatal Tdap on infant pertussis severity is not well-established.
Purpose of the Study:
- To evaluate if maternal Tdap vaccination during pregnancy reduces pertussis severity in infants.
- To compare hospitalization and ICU admission risks for infants born to vaccinated versus unvaccinated mothers.
Main Methods:
- Retrospective cohort study design.
- Analysis of pertussis-infected infants born between 2011-2015.
- Comparison of outcomes between infants whose mothers received prenatal Tdap and those who did not.
Main Results:
- Infants born to Tdap-vaccinated mothers had significantly lower hospitalization rates and shorter hospital stays.
- Maternal Tdap vaccine effectiveness for preventing infant hospitalization was 58% (adjusted).
- No infants born to vaccinated mothers required intubation or died from pertussis.
Conclusions:
- Prenatal Tdap vaccination significantly reduces pertussis-related morbidity in infants.
- Maternal Tdap vaccination is a critical strategy to decrease infant pertussis hospitalizations and ICU admissions.
Background:
All US women are recommended to receive a tetanus, diphtheria, and acellular pertussis (Tdap) vaccine at 27-36 weeks gestation during each pregnancy to reduce the risk of pertussis to their infants. The impact of this strategy on severity of disease among infected infants has not been evaluated.
Methods:
We use a retrospective cohort study design evaluating whether pertussis-infected infants born in 2011-2015 whose mothers received Tdap vaccine during pregnancy had less severe pertussis, resulting in a lower risk of hospitalization or intensive care unit admission compared with infants born to unvaccinated mothers.
Results:
Infected infants of vaccinated mothers were significantly less likely to be hospitalized and had significantly shorter hospital stays compared with infants born to unvaccinated mothers, after adjustment for chronological and gestational age and receipt of diphtheria and tetanus toxoids and acellular pertussis vaccine. Unadjusted and adjusted vaccine effectiveness for preventing hospitalization among infants with pertussis was 72% (95% confidence interval [CI], 49%-85%) and 58% (95% CI 15%-80%), respectively. No infants born to vaccinated mothers required intubation or died of pertussis.
Conclusions:
Infants with pertussis whose mothers received Tdap during pregnancy had a significantly lower risk of hospitalization and intensive care unit admission and shorter hospital stays. Prenatal Tdap vaccination is a critical strategy for reducing the morbidity and mortality from pertussis.
More Related Videos
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
Related Concept Videos
Vaccinations
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Teratogenicity
Probability Laws
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...